Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Clinical trial NCT02531932 · COMPLETED
Trial details
- NCT number
- NCT02531932
- Sponsor
- Amy Tiersten
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-16
- Primary completion
- 2024-09-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.